JAIME FILTZKOWSKI: Open Payments
NPI 1356690549 · NAPA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,535 in 76 payments from 13 companies in 2025. Trend: 2023 $2,213 · 2024 $1,123 · 2025 $1,535
Food & beverage: $1,524Education: $10
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 17 | $407 |
| ABBVIE INC. | 12 | $225 |
| Lilly USA, LLC | 8 | $213 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $195 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $156 |
| Phathom Pharmaceuticals, Inc. | 8 | $122 |
| Organon LLC | 3 | $74 |
| Madrigal Pharmaceuticals | 3 | $47 |
| Braintree Laboratories, Inc. | 1 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
Products named: TREMFYA, OMVOH, ENTYVIO, XIFAXAN, VOQUEZNA, LINZESS, RINVOQ, HADLIMA.
Industry payments across CA — which companies pay providers there.
